Pratidin
2026 · Medical Science Optional Paper I · 10 marksMainsQuestion 7bii

Enumerate five differences between benign and malignant tumours. Describe the mechanisms by which the tumour cells evade the immune system.

10 marks · directive: Enumerate; Describe

Answer

The core of a good answer

Benign tumours are mostly well differentiated, grow slowly within a fibrous capsule, do not invade or metastasise and usually do not return after removal, while malignant tumours are often undifferentiated, faster growing, invasive and metastatic; tumour cells evade immunity by lowering MHC class I or through defects in antigen processing (TAP, tapasin), by immunoediting that selects less immunogenic clones, by producing PD-L1, and by creating a suppressive environment with regulatory T cells, myeloid-derived suppressor cells and cytokines such as TGF-beta and IL-10.

An outline written by upsc.help, not an official UPSC answer; every fact checked by a separate review. How we work

What the question asks

Five marks: a table of five or more differences. Five marks: the immune evasion mechanisms, organised as hiding from recognition and actively suppressing the response, with the therapeutic relevance of checkpoint inhibitors.

Answer outline

Introduction

A benign tumour is a mass of cells that does not invade neighbouring tissue or metastasise and is typically made of cells that strongly resemble a normal cell type; malignant tumours are invasive or metastatic.

Differences between benign and malignant tumours

Mechanisms of immune evasion

Therapeutic relevance

Conclusion

Malignancy is defined by invasion and metastasis, and a cancer must also escape the immune system to survive; checkpoint inhibitors aim to reverse that escape.

Examples and data to cite

Facts

Facts to remember

Sources used for the explanation

Write a timed answer in the app